review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Xu L | |
Rosenfeld MG | |||
Glass CK | |||
P2860 | cites work | Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex | Q22004265 |
Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex | Q22009519 | ||
Composite co-activator ARC mediates chromatin-directed transcriptional activation | Q22009528 | ||
Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor | Q24311650 | ||
Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase | Q29547913 | ||
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function | Q29547918 | ||
Role of CBP/P300 in nuclear receptor signalling | Q29616443 | ||
Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone-regulated chromatin disruption is not sufficient for transcriptional activation | Q33886757 | ||
Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene | Q34460757 | ||
p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation | Q35189958 | ||
Proteasomal regulation of nuclear receptor corepressor-mediated repression | Q35202493 | ||
Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro | Q35210134 | ||
Signal-specific co-activator domain requirements for Pit-1 activation | Q41006466 | ||
Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators | Q41007539 | ||
CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. | Q41010869 | ||
Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation | Q41038113 | ||
Transcription properties of a cell type-specific TATA-binding protein, TRF. | Q41086793 | ||
MSX1 inhibits myoD expression in fibroblast x 10T1/2 cell hybrids. | Q41308304 | ||
Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines | Q41708885 | ||
The p300/CBP family: integrating signals with transcription factors and chromatin | Q45155861 | ||
SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex | Q24311791 | ||
Histone-like TAFs within the PCAF histone acetylase complex | Q24317520 | ||
The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways | Q24320338 | ||
Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 | Q24324556 | ||
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A | Q24336667 | ||
A histone deacetylase corepressor complex regulates the Notch signal transduction pathway | Q24598533 | ||
A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system | Q24601592 | ||
GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors | Q24646387 | ||
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma | Q27765353 | ||
Structure and specificity of nuclear receptor-coactivator interactions | Q27765991 | ||
A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis | Q27860471 | ||
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors | Q27860552 | ||
The transcriptional coactivators p300 and CBP are histone acetyltransferases | Q27860843 | ||
A signature motif in transcriptional co-activators mediates binding to nuclear receptors | Q27860938 | ||
Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex | Q27934812 | ||
The CBP co-activator is a histone acetyltransferase | Q28131758 | ||
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer | Q28245902 | ||
Steroid receptor coactivator-1 is a histone acetyltransferase | Q28248899 | ||
RNA helicase A mediates association of CBP with RNA polymerase II | Q28250576 | ||
Transcription factor-specific requirements for coactivators and their acetyltransferase functions | Q28260156 | ||
Phosphorylated CREB binds specifically to the nuclear protein CBP | Q28265019 | ||
Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300 | Q28270979 | ||
Differential roles of p300 and PCAF acetyltransferases in muscle differentiation | Q28276083 | ||
SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors | Q28279441 | ||
The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities | Q28286772 | ||
Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor | Q28286827 | ||
A transcriptional co-repressor that interacts with nuclear hormone receptors | Q28289864 | ||
Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex | Q28569621 | ||
Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation | Q28577247 | ||
A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression | Q28578229 | ||
Histone acetylation and transcriptional regulatory mechanisms | Q29547707 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 140-7 | |
P577 | publication date | 1999-04-01 | |
P1433 | published in | Current Opinion in Genetics & Development | Q13505684 |
P1476 | title | Coactivator and corepressor complexes in nuclear receptor function | |
P478 | volume | 9 |
Q27677636 | (+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice |
Q35683565 | 1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility |
Q34409624 | 17β-Estradiol-induced interaction of ERα with NPPA regulates gene expression in cardiomyocytes |
Q28343744 | 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma |
Q38328006 | A 5'-distal enhanceosome in the PDGF-A gene is activated in choriocarcinoma cells via ligand-independent binding of vitamin D receptor and constitutive jun kinase signaling |
Q30452390 | A dominant-negative thyroid hormone receptor blocks amphibian metamorphosis by retaining corepressors at target genes. |
Q24805066 | A neuronal-specific differentiation protein that directly modulates retinoid receptor transcriptional activation |
Q37416651 | A noncanonical auxin-sensing mechanism is required for organ morphogenesis in Arabidopsis |
Q39637279 | A novel mammalian complex containing Sin3B mitigates histone acetylation and RNA polymerase II progression within transcribed loci |
Q24559978 | A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters |
Q38725438 | A seasonal switch in histone deacetylase gene expression in the hypothalamus and their capacity to modulate nuclear signaling pathways |
Q38308053 | A single regulatory module of the carbamoylphosphate synthetase I gene executes its hepatic program of expression. |
Q34283520 | A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity |
Q37224312 | A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo |
Q22253330 | A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen |
Q30748653 | ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation |
Q34279131 | ATP-dependent mobilization of the glucocorticoid receptor during chromatin remodeling |
Q47106297 | Acetylation and deacetylation in cancer stem-like cells. |
Q33616296 | Acetylation goes global: the emergence of acetylation biology. |
Q36540294 | Acinus-S' represses retinoic acid receptor (RAR)-regulated gene expression through interaction with the B domains of RARs |
Q30425720 | Acquisition of sexual receptivity: roles of chromatin acetylation, estrogen receptor-alpha, and ovarian hormones |
Q28346239 | Active repression of RAR signaling is required for head formation |
Q57250798 | Activity of the Nurr1 Carboxyl-terminal Domain Depends on Cell Type and Integrity of the Activation Function 2 |
Q44052480 | Age-related changes in nuclear receptor coactivator immunoreactivity in motoneurons of the spinal nucleus of the bulbocavernosus of male rats |
Q36784506 | Aldose Reductase Acts as a Selective Derepressor of PPARγ and the Retinoic Acid Receptor. |
Q39407534 | All-trans retinoic acid induces chromatin remodeling at the promoter of the mouse liver, bone, and kidney alkaline phosphatase gene in C3H10T 1/2 cells |
Q39956276 | Allelic methylation bias of the RARB2 tumor suppressor gene promoter in cancer. |
Q34768098 | Alternative splicing tends to avoid partial removals of protein-protein interaction sites |
Q57165920 | Amplified in Breast Cancer-1 Glutamine Repeat and Prostate Cancer Risk |
Q28215787 | An LXXLL motif in the transactivation domain of STAT6 mediates recruitment of NCoA-1/SRC-1 |
Q38471807 | An array of positioned nucleosomes potentiates thyroid hormone receptor action in vivo |
Q34397082 | Analysis of histone acetyltransferase and histone deacetylase families of Arabidopsis thaliana suggests functional diversification of chromatin modification among multicellular eukaryotes. |
Q24551037 | Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1 |
Q22254743 | Androgen receptor interacts with a novel MYST protein, HBO1 |
Q28208123 | Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6 |
Q35380142 | Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions |
Q38304348 | Androgen-receptor-specific DNA binding to an element in the first exon of the human secretory component gene. |
Q44410588 | Anti-androgenic properties of Compound A, an analog of a non-steroidal plant compound |
Q34776894 | Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer |
Q73154581 | Apparent coactivation due to interference of expression constructs with nuclear receptor expression |
Q24548302 | Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with Its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia |
Q34575811 | Azadirachtin interacts with retinoic acid receptors and inhibits retinoic acid-mediated biological responses |
Q64111564 | BCAS2 Enhances Carcinogenic Effects of Estrogen Receptor Alpha in Breast Cancer Cells |
Q24551188 | BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation |
Q33960598 | Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates |
Q42051354 | Bombyx mori orphan receptor, BmHR78: cDNA cloning, testis abundant expression and putative dimerization partner for Bombyx ultraspiracle. |
Q35192842 | CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex |
Q42527651 | Calmodulin regulates the transcriptional activity of estrogen receptors. Selective inhibition of calmodulin function in subcellular compartments |
Q34426234 | Cardiac myosin heavy chain gene regulation by thyroid hormone involves altered histone modifications |
Q24548253 | Cdc25B functions as a novel coactivator for the steroid receptors |
Q50199467 | Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy. |
Q33197526 | Cell cycle-dependent expression of thyroid hormone receptor-beta is a mechanism for variable hormone sensitivity |
Q39140799 | Cell-specific integration of nuclear receptor function at the genome |
Q40717386 | Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3. |
Q40082702 | Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit |
Q52580795 | Characterization of the activation domains of AP-2 family transcription factors. |
Q33913528 | Characterization of the repressor function of the nuclear orphan receptor retinoid receptor-related testis-associated receptor/germ cell nuclear factor |
Q34405631 | Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism |
Q44932144 | Chenodeoxycholic acid suppresses the activation of acetyl-coenzyme A carboxylase-alpha gene transcription by the liver X receptor agonist T0-901317. |
Q34281377 | Chromatin disruption and histone acetylation in regulation of the human immunodeficiency virus type 1 long terminal repeat by thyroid hormone receptor |
Q34098840 | Chromatin modification and disease |
Q40087324 | Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo |
Q28145097 | Cloning and characterization of RAP250, a novel nuclear receptor coactivator |
Q33605367 | Cloning and characterization of two novel thyroid hormone receptor beta isoforms |
Q28565044 | Co-activator p120 is increased by gonadotropins in the rat ovary and enhances progesterone receptor activity |
Q36053057 | Coactivators in gene regulation by STAT5. |
Q33745111 | Combinatorial codes in signaling and synergy: lessons from pituitary development |
Q35822548 | Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease |
Q40722269 | Comparative study and identification of potent eukaryotic transcriptional repressors in gene switch systems |
Q39681319 | Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alpha1: modulation by the F domain |
Q34735001 | Complex regulation of thyroid hormone action: multiple opportunities for pharmacological intervention |
Q33794816 | Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein |
Q96231444 | Construction of reporter gene assays using CWP and PDR mutant yeasts for enhanced detection of various sex steroids |
Q40805241 | Contribution of steroid receptor coactivator-1 and CREB binding protein in ligand-independent activity of estrogen receptor beta |
Q37099890 | Corepressive action of CBP on androgen receptor transactivation in pericentric heterochromatin in a Drosophila experimental model system |
Q24683232 | Corepressor MMTR/DMAP1 is involved in both histone deacetylase 1- and TFIIH-mediated transcriptional repression |
Q35096766 | Corepressors, nuclear receptors, and epigenetic factors on DNA: a tail of repression |
Q28144708 | Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif |
Q35667790 | Current perspectives on the role of thyroid hormone in growth and development of cerebellum |
Q34102421 | Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity. |
Q33279222 | Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents |
Q24291490 | DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor |
Q35145970 | DNA binding of nuclear hormone receptors influences their structure and function |
Q35176962 | DNA methylation status predicts cell type-specific enhancer activity. |
Q37677559 | Deconstructing repression: evolving models of co-repressor action |
Q40665510 | Decreased RARβ expression induces abundant inflammation and cervical precancerous lesions |
Q34137591 | Deducing the temporal order of cofactor function in ligand-regulated gene transcription: theory and experimental verification |
Q51931355 | Defining core metabolic and transcriptomic responses to oxygen availability in rice embryos and young seedlings. |
Q34196181 | Depletion of MOM1 in non-dividing cells of Arabidopsis plants releases transcriptional gene silencing |
Q34104238 | Developmental mechanisms in the pathogenesis of neurodegenerative diseases |
Q35154309 | Diabetic embryopathy: a role for the epigenome? |
Q73680677 | Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses |
Q43612204 | Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites |
Q33928539 | Differential binding and transcriptional behaviour of two highly related orphan receptors, ROR alpha(4) and ROR beta(1). |
Q24682676 | Differential ligand-dependent protein-protein interactions between nuclear receptors and a neuronal-specific cofactor |
Q33889213 | Differential regulation of the myosin heavy chain genes alpha and beta in rat atria and ventricles: role of antisense RNA |
Q24537217 | Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest |
Q35558605 | Disorder-to-order transition underlies the structural basis for the assembly of a transcriptionally active PGC-1α/ERRγ complex |
Q44731928 | Distinct expression profiles of transcriptional coactivators for thyroid hormone receptors during Xenopus laevis metamorphosis |
Q28593215 | Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer |
Q34061900 | Distinctly different dynamics and kinetics of two steroid receptors at the same response elements in living cells |
Q39958860 | Distribution of acetylated histones resulting from Gal4-VP16 recruitment of SAGA and NuA4 complexes |
Q34561503 | Diversity in the mechanisms of gene regulation by estrogen receptors |
Q28472324 | Drosophila histone deacetylase-3 controls imaginal disc size through suppression of apoptosis |
Q40639094 | Dual action of oestrogens on the mouse constitutive androstane receptor |
Q34859890 | Dynamic access of the glucocorticoid receptor to response elements in chromatin. |
Q34198825 | Dynamic behavior of transcription factors on a natural promoter in living cells |
Q33981483 | Dynamic distribution of nuclear coactivator 4 during mitosis: association with mitotic apparatus and midbodies. |
Q39194197 | Dynamic nature of transcriptional regulation of nuclear receptor target genes in the context of chromatin organization. |
Q44265606 | Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. |
Q40855596 | Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding |
Q35005811 | Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors |
Q37772133 | Dynamics of nuclear receptor target gene regulation. |
Q33292339 | ERalpha and STAT5a cross-talk: interaction through C-terminal portions of the proteins decreases STAT5a phosphorylation, nuclear translocation and DNA-binding |
Q33922035 | Ecdysone receptors and their biological actions |
Q45016647 | Ectopic expression of nonliganded retinoic acid receptor beta abrogates AP-1 activity by selective degradation of c-Jun in cervical carcinoma cells |
Q46491187 | Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation |
Q42513929 | Effects of gender and stress on the regulation of steroid receptor coactivator-1 expression in the rat brain and pituitary. |
Q38937837 | Effects of histone deacetylase inhibitor valproic acid on skeletal myocyte development. |
Q50434868 | Effects of retinoic acid and butyric acid on the expression of prestin and Gata-3 in organotypic cultures of the organ of corti of newborn rats. |
Q58103533 | Efficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review |
Q38557842 | Emerging roles of lysine methylation on non-histone proteins |
Q24292197 | Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR |
Q37983392 | Epigenetic mechanisms are involved in sexual differentiation of the brain |
Q35014402 | Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat |
Q35633556 | Epigenetic regulation by RARα maintains ligand-independent transcriptional activity |
Q33825165 | Epigenetic regulatory mechanisms distinguish retinoic acid-mediated transcriptional responses in stem cells and fibroblasts |
Q36721730 | Epigenetics and the estrogen receptor |
Q28578215 | Expression and localization of RAP250 mRNA in rat ovary: possible implications in follicular development and ovulation |
Q39188632 | Expression of Ski can act as a negative feedback mechanism on retinoic acid signaling. |
Q40627716 | Expression of cAMP Response Element Binding Protein (CREB)‐Binding Protein (CBP) and the Implication in Retinoic Acid‐Inducible Transcription Activation in Human Salivary Gland Adenocarcinoma Cell Line HSG |
Q37293773 | FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth |
Q24601620 | FHL2, a novel tissue-specific coactivator of the androgen receptor |
Q38304825 | FTZ-Factor1 and Fushi tarazu interact via conserved nuclear receptor and coactivator motifs |
Q33517939 | Filling gaps in PPAR-alpha signaling through comparative nutrigenomics analysis. |
Q36351455 | Folates in Plants: Research Advances and Progress in Crop Biofortification |
Q40740525 | Formation of the androgen receptor transcription complex |
Q36414175 | Function of PPARgamma and its ligands in lung cancer |
Q24551050 | Functional interaction between nucleosome assembly proteins and p300/CREB-binding protein family coactivators |
Q40885992 | Functional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex |
Q44470158 | Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo |
Q34137347 | Future perspectives for acute promyelocytic leukemia therapy |
Q36690093 | G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression. |
Q34817460 | GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation |
Q24795458 | Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals |
Q47552479 | Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease. |
Q35802800 | Gene silencing by nuclear orphan receptors |
Q37689132 | Genetic and epigenomic footprints of folate |
Q43299076 | Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study |
Q28255974 | Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes |
Q28077040 | Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy |
Q43574537 | Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity |
Q24292915 | HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription |
Q27939907 | Heme levels switch the function of Hap1 of Saccharomyces cerevisiae between transcriptional activator and transcriptional repressor |
Q28212547 | Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer-amplified transcription coactivator ASC-2 |
Q37175215 | Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties |
Q38362242 | Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer |
Q33732904 | Heterospecies partition analysis reveals binding curve and stoichiometry of protein interactions in living cells |
Q37792465 | Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function |
Q64940256 | Histone deacetylase activity mediates thermal plasticity in zebrafish (Danio rerio). |
Q34290298 | Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? |
Q33850039 | Histone deacetylases: silencers for hire. |
Q28580993 | Histone deacetylation during brain development is essential for permanent masculinization of sexual behavior |
Q35893637 | Hormonal activation of let-7-C microRNAs via EcR is required for adult Drosophila melanogaster morphology and function |
Q34666549 | Hormone activation induces nucleosome positioning in vivo |
Q24307654 | Human ADA3 regulates RARalpha transcriptional activity through direct contact between LxxLL motifs and the receptor coactivator pocket |
Q24607572 | Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells |
Q34283856 | Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. |
Q33662031 | IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer |
Q37464728 | ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression. |
Q36817286 | Identification and characterization of PNRC splicing variants. |
Q40371858 | Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha |
Q35843050 | Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation |
Q73014332 | Identification of a highly conserved domain in the androgen receptor that suppresses the DNA-binding domain-DNA interactions |
Q28116129 | Identification of a novel testicular orphan receptor-4 (TR4)-associated protein as repressor for the selective suppression of TR4-mediated transactivation |
Q24534465 | Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. |
Q24298570 | Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha |
Q24316007 | Identification of the MLL2 complex as a coactivator for estrogen receptor alpha |
Q24550791 | IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways |
Q34150792 | Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance |
Q43712302 | Improvement and validation of the fluorescence-based histone deacetylase assay using an internal standard |
Q57008920 | In vivo regulation of precursor cells in the subventricular zone of adult rat brain by thyroid hormone and retinoids |
Q55691576 | Inactivation of hepatic ATRX in Atrx Foxg1cre mice prevents reversal of aging-like phenotypes by thyroxine. |
Q33591802 | Increasing the complexity of coactivation in nuclear receptor signaling |
Q36559537 | Independent activation of hepatitis B virus biosynthesis by retinoids, peroxisome proliferators, and bile acids. |
Q28189279 | Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype |
Q64061318 | Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy |
Q24550924 | Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split |
Q34587212 | Interaction between hormonal signaling pathways in Drosophila melanogaster as revealed by genetic interaction between methoprene-tolerant and broad-complex |
Q28204036 | Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase |
Q24549599 | Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix |
Q43577061 | Involvement of chromatin and histone acetylation in the regulation of HIV-LTR by thyroid hormone receptor |
Q34057814 | Involvement of p300 in constitutive and HIV-1 Tat-activated expression of glial fibrillary acidic protein in astrocytes |
Q28589180 | Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action |
Q28143258 | Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR |
Q34889102 | Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression |
Q34444310 | LIM-only protein FHL2 is a positive regulator of liver X receptors in smooth muscle cells involved in lipid homeostasis |
Q34462574 | LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. |
Q24678871 | Ligand-independent activation of estrogen receptor alpha by XBP-1 |
Q33957129 | Ligand-protein interactions in nuclear receptors of hormones. |
Q44290665 | Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta |
Q28215632 | Linking beta-catenin to androgen-signaling pathway |
Q33642453 | Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1. |
Q24540319 | MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300. |
Q44010956 | MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. |
Q52571560 | Makorin RING finger protein 1 (MKRN1) has negative and positive effects on RNA polymerase II-dependent transcription. |
Q32061962 | Mass-spectrometric analysis of agonist-induced retinoic acid receptor gamma conformational change |
Q34064165 | Mechanism of action of estrogens and selective estrogen receptor modulators |
Q47638286 | Mechanism underlying the suppressor activity of retinoic acid on IL4-induced IgE synthesis and its physiological implication |
Q33892757 | Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. |
Q34099654 | Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB. |
Q35901064 | Mechanotransduction Mechanisms for Intraventricular Diastolic Vortex Forces and Myocardial Deformations: Part 2. |
Q34328117 | Metabolic conversion as a pre-receptor control mechanism for lipophilic hormones |
Q36328486 | Metabolic stress in the myocardium: adaptations of gene expression. |
Q74234880 | Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells |
Q40219178 | Microarray analysis of gene-expression profile in hepatocellular carcinoma cell, BEL-7402, with stable suppression of hLRH-1 via a DNA vector-based RNA interference |
Q34658571 | Modelling haematopoietic malignancies in the mouse and therapeutical implications |
Q28579299 | Modulation of androgen receptor transactivation by the SWI3-related gene product (SRG3) in multiple ways |
Q34519720 | Modulation of glucocorticoid receptor-interacting protein 1 (GRIP1) transactivation and co-activation activities through its C-terminal repression and self-association domains |
Q39447843 | Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. |
Q35062563 | Molecular action of androgens |
Q37688472 | Molecular and genetic studies suggest that thyroid hormone receptor is both necessary and sufficient to mediate the developmental effects of thyroid hormone |
Q40884489 | Molecular chaperones activate the Drosophila ecdysone receptor, an RXR heterodimer |
Q36389347 | Molecular defects in cardiac myofibrillar proteins due to thyroid hormone imbalance and diabetes |
Q33823770 | Molecular determinants of NOTCH4 transcription in vascular endothelium |
Q34310272 | Molecular mechanisms of glucocorticoid action in rheumatic autoimmune diseases |
Q34453159 | Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions |
Q33962326 | Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors |
Q35062458 | Mouse cancer models as a platform for performing preclinical therapeutic trials |
Q50335765 | Multimeric Coactivator Complexes for Steroid/Nuclear Receptors. |
Q36002736 | Multiple mechanisms of growth hormone-regulated gene transcription |
Q28218138 | Murine Sall1 represses transcription by recruiting a histone deacetylase complex |
Q35687733 | Mutagenesis Study Reveals the Rim of Catalytic Entry Site of HDAC4 and -5 as the Major Binding Surface of SMRT Corepressor |
Q48327642 | NCoR1-independent mechanism plays a role in the action of the unliganded thyroid hormone receptor. |
Q24298650 | NRIP, a novel nuclear receptor interaction protein, enhances the transcriptional activity of nuclear receptors |
Q24318233 | Negative modulation of androgen receptor transcriptional activity by Daxx |
Q34268802 | New insights into receptor ligand binding domains from a novel assembly assay |
Q40191181 | Noncoding RNA synthesis and loss of Polycomb group repression accompanies the colinear activation of the human HOXA cluster |
Q55884279 | NuRD and SIN3 |
Q36772290 | Nuclear Receptor Cofactors in PPARgamma-Mediated Adipogenesis and Adipocyte Energy Metabolism |
Q46735339 | Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer |
Q38234421 | Nuclear receptor Rev-erbα: up, down, and all around |
Q36589100 | Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo |
Q33745092 | Nuclear receptor cofactors as chromatin remodelers |
Q34537625 | Nuclear receptor coregulators: multiple modes of modification |
Q40743785 | Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation |
Q41639915 | Nuclear receptor corepressors Ncor1 and Ncor2 (Smrt) are required for retinoic acid-dependent repression of Fgf8 during somitogenesis |
Q34666809 | Nuclear receptor regulation of hepatic function |
Q26825692 | Nuclear receptors and their selective pharmacologic modulators |
Q38766346 | Nuclear translocation of the cardiac L-type calcium channel C-terminus is regulated by sex and 17β-estradiol. |
Q34282476 | Nuclear-receptor interactions on DNA-response elements |
Q53408223 | Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. |
Q42779812 | Orphan nuclear receptor TR2, a mediator of preadipocyte proliferation, is differentially regulated by RA through exchange of coactivator PCAF with corepressor RIP140 on a platform molecule GRIP1. |
Q33961750 | Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cells |
Q22254231 | Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA |
Q44594527 | Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor α |
Q28115180 | PA1 protein, a new competitive decelerator acting at more than one step to impede glucocorticoid receptor-mediated transactivation |
Q40355706 | PI3K-AKT signaling is a downstream effector of retinoid prevention of murine basal cell carcinogenesis |
Q34300756 | PIASy-mediated repression of the androgen receptor is independent of sumoylation |
Q34896634 | PNRC accumulates in the nucleolus by interaction with B23/nucleophosmin via its nucleolar localization sequence |
Q46484275 | PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose |
Q42584983 | PTB-associated splicing factor (PSF) functions as a repressor of STAT6-mediated Ig epsilon gene transcription by recruitment of HDAC1 |
Q34181759 | Parent-of-origin-specific binding of nuclear hormone receptor complexes in the H19-Igf2 imprinting control region |
Q37891181 | Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease |
Q28345519 | Peroxisomal bifunctional enzyme binds and activates the activation function-1 region of the peroxisome proliferator-activated receptor alpha |
Q34405645 | Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond |
Q28513089 | Peroxisome proliferator-activated receptor-binding protein null mutation results in defective mammary gland development |
Q39663357 | Pharicin B stabilizes retinoic acid receptor-α and presents synergistic differentiation induction with ATRA in myeloid leukemic cells |
Q34236635 | Phosphorylation and activation of androgen receptor by Aurora-A |
Q34795858 | Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis |
Q39940557 | Post-TATA Binding Protein Recruitment Clearance of Gcn5-Dependent Histone Acetylation within Promoter Nucleosomes |
Q45223754 | Posttranscriptional regulation of myosin heavy chain expression in the heart by triiodothyronine |
Q91762131 | Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer's disease |
Q36363049 | Potential uses of T3 in the treatment of human disease |
Q24323389 | Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression |
Q24297189 | Prospero-related homeobox (Prox1) is a corepressor of human liver receptor homolog-1 and suppresses the transcription of the cholesterol 7-alpha-hydroxylase gene |
Q34136185 | Proteins interacting with the mammalian estrogen receptor: proposal for an integrated model for estrogen receptor mediated regulation of transcription |
Q44214643 | Proteomic comparison of human and great ape blood plasma reveals conserved glycosylation and differences in thyroid hormone metabolism |
Q24338281 | Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells |
Q33292217 | Prothymosin alpha associates with the oncoprotein SET and is involved in chromatin decondensation |
Q24552170 | Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity |
Q34236652 | Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities |
Q24322855 | Purification and identification of a novel complex which is involved in androgen receptor-dependent transcription |
Q31892738 | Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes |
Q73230918 | RAC-3 is a NF-kappa B coactivator |
Q40565112 | RARgamma acts as a tumor suppressor in mouse keratinocytes |
Q28217579 | RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding |
Q37277846 | Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development |
Q28377418 | Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions |
Q33903836 | Redefining hormone resistance in prostate cancer |
Q61818422 | Redoxins as gatekeepers of the transcriptional oxidative stress response |
Q35874448 | Regulated clearance of histone deacetylase 3 protects independent formation of nuclear receptor corepressor complexes. |
Q47393112 | Regulation of Signal Transduction by DJ-1. |
Q44616310 | Regulation of androgen receptor expression at the onset of functional overload in rat plantaris muscle |
Q33882753 | Regulation of cytochrome P450 (CYP) genes by nuclear receptors. |
Q37256023 | Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation |
Q22254367 | Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization |
Q32062002 | Regulation of mouse kappa opioid receptor gene expression by retinoids. |
Q42481656 | Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction |
Q33922396 | Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor |
Q37477712 | Regulatory diversity of TUP1 in Cryptococcus neoformans |
Q39124248 | Relationship between epigenetic regulation, dietary habits, and the developmental origins of health and disease theory |
Q52174747 | Repression and activation of transcription of phosphoenolpyruvate carboxykinase gene during liver development. |
Q37084818 | Repression of the cardiac myosin light chain-2 gene in skeletal muscle requires site-specific association of antithetic regulator, Nished, and HDACs |
Q40701086 | Requirement for multiple domains of the protein arginine methyltransferase CARM1 in its transcriptional coactivator function |
Q37175201 | Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing |
Q24291241 | Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription |
Q31114537 | Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines |
Q40609894 | Retinoic acid inhibits interleukin-4-induced eotaxin production in a human bronchial epithelial cell line |
Q34244416 | Retinoic acid receptor alpha (RAralpha) Mutations in Human Leukemia. |
Q37062449 | Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties |
Q34004662 | Retinoic acid receptor alpha1 variants, RARalpha1DeltaB and RARalpha1DeltaBC, define a new class of nuclear receptor isoforms |
Q24537553 | Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter |
Q24323284 | Retinoic acid-dependent activation of the polycystic kidney disease-1 (PKD1) promoter |
Q37598771 | Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting |
Q45286557 | Retinoid signaling competence and RARbeta-mediated gene regulation in the developing mammalian telencephalon. |
Q35217391 | Retinoid target genes in acute promyelocytic leukemia |
Q34098068 | Retinoid-dependent antagonism of serum response factor transactivation mediated by transcriptional coactivator proteins |
Q36509253 | Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages |
Q34770626 | Retinoid-related Orphan Receptors (RORs): Roles in Cellular Differentiation and Development. |
Q24642725 | Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis |
Q34976906 | Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism |
Q35567239 | Retinoids in cancer therapy and chemoprevention: promise meets resistance |
Q37788067 | Retinoids regulate stem cell differentiation |
Q28564938 | Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5 |
Q37973431 | Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization |
Q34290239 | Role of protein methylation in chromatin remodeling and transcriptional regulation |
Q34541307 | Role of transcription factors in the pathogenesis of pituitary adenomas: a review |
Q31798023 | Role reversal: new insights from new ligands for the xenobiotic receptor CAR. |
Q26796409 | Roles of transcriptional factor 7 in production of inflammatory factors for lung diseases |
Q30440069 | SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways |
Q35641879 | STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid receptor-mediated induction and repression |
Q33947738 | Segmentation gene product Fushi tarazu is an LXXLL motif-dependent coactivator for orphan receptor FTZ-F1 |
Q24540092 | Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription |
Q24302292 | Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene |
Q47229962 | Sequence and expression analyses of KIX domain proteins suggest their importance in seed development and determination of seed size in rice, and genome stability in Arabidopsis |
Q28190290 | Sequence-specific assignment of the PAH2 domain of Sin3B free and bound to Mad1 |
Q40625890 | Short linear motif acquisition, exon formation and alternative splicing determine a pathway to diversity for NCoR-family co-repressors. |
Q33677015 | Signaling routes to CREM and CREB: plasticity in transcriptional activation. |
Q36871666 | Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex |
Q35964130 | Sin3: a flexible regulator of global gene expression and genome stability. |
Q37061970 | Smad-Dependent Recruitment of a Histone Deacetylase/Sin3A Complex Modulates the Bone Morphogenetic Protein-Dependent Transcriptional Repressor Activity of Nkx3.2 |
Q36197069 | Somite-Derived Retinoic Acid Regulates Zebrafish Hematopoietic Stem Cell Formation |
Q44185391 | Specificity of thyroid hormone receptor subtype and steroid receptor coactivator-1 on thyroid hormone action |
Q31440310 | Steroid hormone activity of flavonoids and related compounds. |
Q33813420 | Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function. |
Q36421655 | Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin |
Q33987672 | Steroid regulation of postembryonic development and reproduction in Drosophila |
Q43925897 | Sterol regulatory element-binding protein-1 interacts with the nuclear thyroid hormone receptor to enhance acetyl-CoA carboxylase-alpha transcription in hepatocytes |
Q40362927 | Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells |
Q33813416 | Strategies for transcriptional activation by steroid/nuclear receptors |
Q24336232 | Structural and functional characterization of a novel type of ligand-independent RXR-USP receptor |
Q40877928 | Structural and functional divergence of a nuclear receptor of the RXR family from the trematode parasite Schistosoma mansoni |
Q28594313 | Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors |
Q27641089 | Structural basis for bile acid binding and activation of the nuclear receptor FXR |
Q35104166 | Structural basis for corepressor assembly by the orphan nuclear receptor TLX. |
Q27630646 | Structural insights into the mode of action of a pure antiestrogen |
Q47145058 | Structure and Functional Analysis of Promoters from Two Liver Isoforms of CPT I in Grass Carp Ctenopharyngodon idella. |
Q40641807 | Subcellular localization and mechanisms of nucleocytoplasmic trafficking of steroid receptor coactivator-1. |
Q36017139 | Suppression of Adipocyte Differentiation by Foenumoside B from Lysimachia foenum-graecum Is Mediated by PPARγ Antagonism |
Q43583333 | Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. |
Q44586126 | Synthesis of a high-affinity fluorescent PPARgamma ligand for high-throughput fluorescence polarization assays |
Q38177196 | Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. |
Q21284161 | TBLR1 regulates the expression of nuclear hormone receptor co-repressors |
Q24300818 | TIP27: a novel repressor of the nuclear orphan receptor TAK1/TR4 |
Q28255619 | TIP30 interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates c-myc transcription |
Q24537630 | TRAP/SMCC/mediator-dependent transcriptional activation from DNA and chromatin templates by orphan nuclear receptor hepatocyte nuclear factor 4. |
Q37284561 | Targeted chromatin binding and histone acetylation in vivo by thyroid hormone receptor during amphibian development |
Q34732688 | Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway |
Q38441104 | TcoF-DB v2: update of the database of human and mouse transcription co-factors and transcription factor interactions |
Q24607892 | TcoF-DB: dragon database for human transcription co-factors and transcription factor interacting proteins |
Q39458882 | Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1. |
Q35131700 | Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases |
Q30430463 | Tgif1 represses apolipoprotein gene expression in liver |
Q37332415 | The 26-amino acid beta-motif of the Pit-1beta transcription factor is a dominant and independent repressor domain |
Q24523980 | The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein |
Q24292680 | The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor |
Q35040153 | The NR4A2 nuclear receptor is recruited to novel nuclear foci in response to UV irradiation and participates in nucleotide excision repair |
Q24816133 | The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses |
Q28513184 | The PCAF acetylase complex as a potential tumor suppressor |
Q34090732 | The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes |
Q28343797 | The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II) |
Q39455172 | The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export |
Q36957831 | The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain. |
Q42004851 | The WHHERE coactivator complex is required for retinoic acid-dependent regulation of embryonic symmetry. |
Q28378184 | The anti-estrogen hydroxytamoxifen is a potent antagonist in a novel yeast system |
Q73515650 | The control of Xenopus embryonic primary neurogenesis is mediated by retinoid signalling in the neurectoderm |
Q35043461 | The dual role of ultraspiracle, the Drosophila retinoid X receptor, in the ecdysone response |
Q45179478 | The effect of sodium butyrate in combination with ATRA on the proliferation/differentiation of SKM-1. |
Q24537671 | The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. |
Q24600264 | The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor |
Q28202057 | The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiation |
Q24336423 | The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling |
Q24548305 | The modified human DNA repair enzyme O(6)-methylguanine-DNA methyltransferase is a negative regulator of estrogen receptor-mediated transcription upon alkylation DNA damage |
Q38697860 | The nature of the GRE influences the screening for GR-activity enhancing modulators. |
Q39705022 | The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells |
Q24554362 | The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression |
Q24815982 | The proliferating cell nuclear antigen regulates retinoic acid receptor transcriptional activity through direct protein-protein interaction. |
Q34365414 | The role of SGK1 in hormone-regulated sodium transport |
Q35671179 | The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors |
Q35193858 | The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. |
Q39597497 | The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling |
Q42153519 | The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function |
Q28285366 | The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains |
Q37140783 | Thyroid hormone and cerebellar development |
Q50026830 | Thyroid hormone receptor localization in target tissues. |
Q35802818 | Thyroid hormone receptor subtypes and their interaction with steroid receptor coactivators |
Q24678281 | Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator |
Q35230257 | Thyroid hormone regulates the expression of the sonic hedgehog signaling pathway in the embryonic and adult Mammalian brain |
Q43938722 | Thyroid hormone regulation of a transcriptional coactivator in Xenopus laevis: implication for a role in postembryonic tissue remodeling |
Q34047802 | Thyroid hormone regulation of apoptotic tissue remodeling: implications from molecular analysis of amphibian metamorphosis |
Q30940081 | Thyroid hormone stimulates acetyl-coA carboxylase-alpha transcription in hepatocytes by modulating the composition of nuclear receptor complexes bound to a thyroid hormone response element |
Q39218620 | Time-integrated fluorescence cumulant analysis and its application in living cells |
Q28251356 | Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation |
Q52049507 | Tissue- and gene-specific recruitment of steroid receptor coactivator-3 by thyroid hormone receptor during development. |
Q28386593 | To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator |
Q37454297 | Trans-regulation of histone deacetylase activities through acetylation |
Q28651703 | Transcript profiling of Populus tomentosa genes in normal, tension, and opposite wood by RNA-seq |
Q39644401 | Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity |
Q28189040 | Transcriptional activation by STAT6 requires the direct interaction with NCoA-1 |
Q38660201 | Transcriptional activation by hepatocyte nuclear factor-4 in a cell-free system derived from rat liver nuclei |
Q51494268 | Transcriptional activation by the thyroid hormone receptor through ligand-dependent receptor recruitment and chromatin remodelling. |
Q35127128 | Transcriptional coactivator PC4 stimulates promoter escape and facilitates transcriptional synergy by GAL4-VP16 |
Q28199910 | Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250 |
Q33898960 | Transcriptional control of T cell development |
Q33851832 | Transcriptional regulation by cyclic AMP-responsive factors |
Q34401921 | Transcriptional regulation of hemopoiesis |
Q33904338 | Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells |
Q40816966 | Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor |
Q45872399 | Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo |
Q44333035 | Triiodothyronine-mediated myosin heavy chain gene transcription in the heart |
Q35781803 | Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor alpha. |
Q28366303 | Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells |
Q36344273 | Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor |
Q24530630 | WBP-2, a WW domain binding protein, interacts with the thyroid-specific transcription factor Pax8 |
Q27641169 | X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch |
Q42620669 | XTIF2, a Xenopus homologue of the human transcription intermediary factor, is required for a nuclear receptor pathway that also interacts with CBP to suppress Brachyury and XMyoD. |
Q38921373 | Zebrafish retinoic acid receptors function as context-dependent transcriptional activators |
Q30156984 | c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation |
Q33968417 | p300 forms a stable, template-committed complex with chromatin: role for the bromodomain |
Q33199648 | p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene |
Search more.